Upon closing, expected by October 1, 2025, Portsmouth will become Vext's fifth fully consolidated dispensary in Ohio. The Company expects to bring additional locations online through late 2025 and early 2026, progressing toward the state's eight-store cap.Vancouver, British Columbia--(Newsfile Corp. - September 17, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, today announced that it has received ...

Core Viewpoint - Tilray Brands, Inc. is launching a new limited-edition line of premium cannabis flower called BC Selects under its Broken Coast brand, emphasizing quality and unique phenotypes from its genetic library [1][6]. Product Launch - BC Selects will feature small-batch, non-irradiated cannabis flower selected for exceptional qualities, including dense cola structure and pronounced terpene profiles [2]. - The first strain, Sprits 26, offers a balanced hybrid experience with a THC content of 28–34% and a terpene content of 2–5%, showcasing dominant terpenes like nerolidol and caryophyllene [3]. - Alongside BC Selects, Broken Coast is also introducing a modern version of the iconic Blue Dream strain in various formats [5]. Brand Commitment - Broken Coast is dedicated to pushing the boundaries of craft cannabis by curating exceptional phenotypes and prioritizing quality over quantity [6]. - The brand's philosophy emphasizes a relentless pursuit of purity and quality, involving meticulous monitoring of growing conditions and adherence to strict protocols [8][9]. Company Overview - Tilray Brands operates globally, focusing on lifestyle and consumer packaged goods, with a mission to inspire joy through innovative products [10]. - The company supports over 40 brands across more than 20 countries, including cannabis offerings and craft beverages [10].

California lawmakers have passed sweeping legislation to crack down on hemp-derived THC products, tightening oversight of a booming gray market. https://t.co/qc4zk5PTDJ https://t.co/NPX5nkXj65 ...

WATCH: How Cheech & Chong Turned Their Legacy Into A $100 Million Cannabis Empire https://t.co/AHeq0exRih https://t.co/k6Ddroz7kr ...

Cannara Biotech Conference Summary Company Overview - **Company Name**: Cannara Biotech Inc. - **Stock Symbol**: LOVE (TSXV) - **Industry**: Canadian Cannabis - **Founded**: 2018 - **Headquarters**: Quebec, Canada - **Facilities**: Operates over 1.6 million square feet across two fully owned facilities in Quebec [2][5] Core Business and Market Position - Cannara Biotech is a vertically integrated cannabis company focused on producing premium-grade cannabis at scale, emphasizing profitability, innovation, and long-term value creation [2][4] - Currently the **seventh largest producer** in Canada by sales and **second largest** in Quebec, with a **12.8% market share** in Quebec, up from 9.7% a year ago [5][17] - Annualized production run rate is approximately **50,000 kilograms** (50 million grams) [5][6] Financial Performance - **Q3 2025**: Best quarterly financial results in the company's history - **Nine months of 2025**: - Net revenue: **$80 million** - Gross profit: **$32.7 million** - Gross margin: **41%**, with steady quarter-over-quarter increases [9][10] - Adjusted EBITDA: **$20.7 million** (26% of revenues) [10] - Net income: **$9.8 million**, a **53% increase** from the previous year [10] - **Cash Flow**: Generated **$17.2 million** in operating cash flow and **$12.3 million** in free cash flow in the first nine months of 2025 [11] Operational Highlights - Achieved a **26% increase** in capacity over the past year without additional capital costs [6][9] - Vertical integration allows full control over the cannabis supply chain, enhancing quality and efficiency [7][24] - Upcoming launch of a new vape category in Quebec, with **20% retail shelf space** already secured [8][17] Competitive Advantages - Strong operational platform with a focus on premium quality, scalable operations, and cost leadership [8][9] - Access to Quebec's low electricity rates of **$0.059 per kilowatt**, significantly lower than other provinces [26] - High barriers to entry in Quebec due to strict regulations on sales and marketing, allowing Cannara to thrive without heavy promotional activities [26][27] Strategic Initiatives - Plans for a **$10 million investment** in a new dedicated processing center to support growth and expand capacity to **100,000 kilograms** annually [16][24] - Focus on internal growth rather than external acquisitions, emphasizing operational discipline and quality [25][27] Market Trends and Outlook - The Canadian cannabis market is experiencing a shift, with a **41% surge** in estimated retail sales year-over-year, positioning Cannara as a leader in growth [16][17] - The company is well-prepared to meet unserved demand and capitalize on upcoming market opportunities, particularly in the vape segment [8][17] Conclusion - Cannara Biotech is positioned as a dominant player in the Canadian cannabis market, with a strong financial performance, operational efficiencies, and a clear growth strategy focused on quality and innovation [2][9][27]

Aurora Cannabis Inc. (NASDAQ:ACB) is among the 12 Best Marijuana Stocks to Buy According to Analysts. Aurora Cannabis Inc. (NASDAQ:ACB) and German healthcare technology company Copeia have released an English-language version of the Physician Experience Platform (PEP). The platform has over 130 anonymized case studies detailing real-world medicinal cannabis treatments, including patient history, symptoms, dose, outcomes, and concurrent medicines. PEP, which is initially available in Canada, the United King ...

Core Insights - Cronos Group Inc. reported $33.5 million in net revenue for Q2 2025, marking a 21% increase year over year driven by strong cannabis flower sales in Israel and international markets, consolidation of Cronos GrowCo, and improved Canadian extract sales [1][3] - Gross profit rose from $8.2 million in Q2 2024 to $14.5 million, while adjusted EBITDA increased by $12.7 million to $1.7 million [1] - Despite revenue growth, Cronos reported a net loss of $38.5 million [1] Financial Performance - Net revenue for Q2 2025: $33.5 million, a 21% increase year over year [1] - Gross profit increased from $8.2 million to $14.5 million [1] - Adjusted EBITDA climbed to $1.7 million from the previous year's figure [1] - Net loss reported at $38.5 million [1] Market Position and Strategy - PEACE NATURALS® remains Israel's leading cannabis brand, contributing to record sales [3] - Planned growth in flower capacity and strong global momentum are expected to address supply limitations in Canada [3] - Flower sales generated approximately $2.2 million for Cronos GrowCo [3] - The company maintains a robust balance sheet with $834 million in cash and no debt, supporting international growth and brand innovation [3]

Industry Overview - The Canadian cannabis sector is crucial for investors looking to tap into the expanding U.S. marijuana market, which generated over $33 billion in sales in 2024 and is projected to exceed $50 billion by 2030 due to increasing state-level legalization and consumer demand [1][3] - Recent discussions around federal reform and rescheduling cannabis could benefit Canadian companies with U.S. partnerships or expansion plans, making them attractive to investors [1][3] Company Highlights - **Tilray Brands, Inc. (TLRY)**: - Operates in cultivation, processing, and distribution across Canada, Europe, and the U.S., focusing on hemp-derived beverages and wellness products, reaching about 1,000 retail stores [5][7] - Reported annual revenue of approximately $821 million with a gross profit of around $240 million, but net income remains negative with losses exceeding $2 billion [7] - **Canopy Growth Corporation (CGC)**: - One of the largest cannabis companies in Canada, with a strong presence in the U.S. through brands and subsidiaries rather than direct dispensary ownership [8][10] - Achieved year-over-year revenue growth of about 9%, but gross margin fell to 25% from 35% a year earlier, indicating financial strain [10] - **Village Farms International, Inc. (VFF)**: - Transitioned from agricultural production to cannabis, operating one of the largest cannabis greenhouse facilities in Canada with over 2.2 million square feet [12][14] - Reported annual revenue of about $336 million, a 17% increase from the previous year, but posted a net loss of approximately $36 million [14] Strategic Focus - Tilray is diversifying through beverages and wellness products, while Canopy is focusing on cost-cutting and U.S. brand partnerships [15] - Village Farms emphasizes efficiency and international expansion, positioning itself as one of the lowest-cost producers in Canada [14][15] Market Outlook - The Canadian cannabis sector faces challenges from oversupply and regulatory uncertainty, but leading companies are adapting their strategies to remain competitive [15][16] - September 2025 is seen as a critical period for the sector, with investors closely monitoring earnings, cost controls, and expansion efforts [16]

Company Overview - Vireo Growth Inc. has commenced the sale of adult-use cannabis at all eight Green Goods® dispensaries in Minnesota as of September 16, 2025 [1][2] - The company has been operating in Minnesota's medical cannabis market since 2014, serving tens of thousands of patients [2][4] - Vireo aims to expand access, improve product quality, and support the transition to a sustainable adult-use market in Minnesota [2][4] Market Impact - The launch of the adult-use cannabis market in Minnesota, with a population of 5.7 million, is expected to drive strong organic revenue growth for Vireo [1][2] - Vireo is one of the state's licensed adult-use cannabis cultivators and retailers, positioning itself to benefit from the new market dynamics [2][4] Product Offering - Green Goods® dispensaries offer a comprehensive range of medical and adult-use cannabis products, including flower, pre-rolls, edibles, and beverages [3][4] - The dispensaries are strategically located in key areas such as Minneapolis, Blaine, Bloomington, Burnsville, Duluth, Moorhead, Rochester, and Woodbury [3] Leadership Commentary - Amber Shimpa, President of Vireo, expressed pride in making products available to all Minnesotans while maintaining commitment to medical patients [3] - Alexandra Breant, Head of Market in Minnesota, highlighted the significance of this milestone in expanding access and building community [3]

Core Insights - Glow Lifetech Corp is expanding its MOD™ and .decimal™ brands into the Saskatchewan cannabis retail market, marking a significant step in its national growth strategy [1][2][3] Expansion Strategy - The expansion into Saskatchewan follows successful entries into Ontario and New Brunswick, with the company securing 10 product listings in Saskatchewan, which will create a new long-term revenue stream [2][4] - The company aims to leverage its success in Ontario to scale its operations nationally in a disciplined manner [2][3] Commercial Momentum - The Saskatchewan expansion is part of a broader strategy that includes deepening penetration in Ontario while entering new provinces [4][5] - Recent commercial progress indicates strong momentum, with MOD™ being established among Ontario's leading oil brands [4][5] Business Model and Innovation - Glow Lifetech's disciplined growth strategy combines expanded retail distribution, new provincial launches, and ongoing product innovation, reinforcing the fundamentals of the business [5] - The company's scalable model positions it for sustainable growth and long-term value creation [5]